Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

98 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

NCT04580485

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +59 more
Locations
  • Cedars-Sinai Medical Center West Hollywood, California, United States
  • University of Maryland-Greenebaum Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 27 locations
View Trial Details
Completed

A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)

NCT04489888

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0265) New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center & Research Institute ( Site 0214) Newark, Delaware, United States
  • Baptist MD Anderson Cancer Center ( Site 0215) Jacksonville, Florida, United States
  • Orlando Health, Inc. ( Site 0216) Orlando, Florida, United States
View all 35 locations
View Trial Details
Completed

Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC

NCT05053737

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Colorado Research Center Aurora, Colorado, United States
  • Memorial Health Central Colorado Springs, Colorado, United States
  • Memorial Hospital North Colorado Springs, Colorado, United States
  • Highlands Ranch Hospital Highlands Ranch, Colorado, United States
View Trial Details
Completed

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

NCT03997968

Conditions
Adnexal Diseases, Blood Protein Disorders, Breast Cancer, +68 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Stanford Comprehensive Cancer Center Stanford, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

NCT04144517

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations
  • Mural Oncology Investigational Site Miami, Florida, United States
  • Mural Oncology Investigational Site Atlanta, Georgia, United States
  • Mural Oncology Investigational Site Minneapolis, Minnesota, United States
  • Mural Oncology Investigational Site New York, United States
View Trial Details
Completed

A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

NCT04474470

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colorectal Adenocarcinoma, +14 more
Locations
  • California Cancer Associates for Research and Excellence Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSD Moores Cancer Center San Diego, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +47 more
Locations
  • GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow, Russia
  • FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia Moscow, Russia
  • FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia Moscow, Russia
  • National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details

Related conditions